Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Oncologist|March 19, 2022
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR InsertionAlessandro Morabito, Anna Manzo, Agnese Montanino, et al.
Frontiers in Oncology|September 16, 2022
Lurbinectedin in small cell lung cancerAnna Manzo, Vincenzo Sforza, Guido Carillio, et al.
Exploration of Targeted Anti-Tumor Therapy|May 16, 2024
Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team workingAlessandro Morabito, Edoardo Mercadante, Paolo Muto, et al.
Future Oncology (London, England)|August 22, 2019
Pembrolizumab in lung cancer: current evidence and future perspectivesGiuliano Palumbo, Guido Carillio, Anna Manzo, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancerGiuliano Palumbo, Giovanna Esposito, Guido Carillio, et al.
Cancers|September 9, 2020
Immunotherapy in Small Cell Lung CancerGiovanna Esposito, Giuliano Palumbo, Guido Carillio, et al.
Expert Opinion on Drug Safety|May 14, 2020
The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancerAnna Manzo, Guido Carillio, Agnese Montanino, et al.
Risk Management and Healthcare Policy|March 3, 2026
An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital SettingAlessandro Morabito, Piera Maiolino, Stefania D'Auria, et al.
JCO Oncology Practice|November 16, 2022
Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective AnalysisAlessandro Morabito, Edoardo Mercadante, Paolo Muto, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trialsAlessandro Morabito, Maria Carmela Piccirillo, Paolo Maione, et al.
Pageof 3